NICHD - News Releases

All News releases related to the Contraception & Reproductive Health (CRH) Branch

Your search for: All Related News Releases All Years returned the following 10 results:

08/15/06		New Findings Offer More Complete View Of Breast Cancer Gene Mutations in U.S. Population
BETHESDA, Md., Tues., Aug. 15, 2006 - A large study funded by the National Institutes of Health today provided the clearest picture yet of the prevalence in the U.S. population of mutations in two genes associated with an increased risk of breast cancer. The genes are called Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2). In addition, the study identified key predictors for assessing which women are most likely to carry these genetic mutations.

04/12/06		Combined Surgery Reduces Incontinence In Women with Pelvic Organ Prolapse
By performing two surgical procedures during the same operation, researchers in an NIH network reduced by half the incidence of urinary incontinence in women with a condition known as pelvic organ prolapse.

02/07/05		Bone Density Appears to Recover After Adolescents Discontinue Injected Contraceptive
Lower bone density appears to recover in adolescent females once they stop using the injected contraceptive depot medroxyprogesterone acetate (DMPA), according to a study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.

08/23/04		Depo Provera Appears to Increase Risk for Chlamydial and Gonococcal Infections
The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman's risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three fold when compared to women not using a hormonal contraceptive, according to a study jointly funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health and the U.S. Agency for International Development's Office of Population and Reproductive Health.

11/29/02		Study Confirms Breast Cancer Risk in Continuous Combined Hormone Therapy Risk Begins to Return to Normal After Women Stop Taking Hormones
Researchers confirmed that a daily, combined dose of estrogen and progestin increases breast cancer risk in post menopausal women, but added that this risk begins to return to normal about six months after women stop taking the hormones.

09/06/02		Bone Loss in Depo-Provera Users Largely Reversible
A new study confirms earlier reports that Depo-Provera, an injectable contraceptive popular among young and low-income American women, is strongly associated with bone density loss.

06/26/02		NICHD Study Finds No Association Between Oral Contraceptive Use and Breast Cancer For Women from 35 to 64
Women between the ages of 35 and 64 who took oral contraceptives at some point in their lives are no more likely to develop breast cancer than are other women the same age, according to findings from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Women's Contraceptive and Reproductive Experiences Study (Women's CARE).

06/18/02		New Study Finds Vasectomy Does Not Increase Prostate Cancer Risk
Contrary to some earlier studies, a new study funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) found that men who undergo vasectomies are no more likely to develop prostate cancer than are men who do not.

06/17/02		Few Women Regret Sterilization Procedures
Few of the women who undergo tubal sterilization or whose husbands undergo vasectomy later go on to regret either procedure, according to a study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and conducted by the Centers for Disease Control and Prevention (CDC).

12/06/00		Tubal Sterilization Poses No Greater Risk of Menstrual Abnormalities, Study Finds
The largest, most comprehensive study of its kind to date has found that women who have undergone tubal sterilization are at no greater risk for menstrual abnormalities than are women who have not had the procedure, settling a debate within the medical community.

If you are a member of the media and have questions about an NICHD news release or research, or if you would like to schedule an interview with an NICHD scientist or grantee, please contact the Public Information and Communications Branch at 301-496-5133 or by fax at 301-496-7101.